Related Experiment Videos
Controlled release of vitamin E from thermo-responsive polymeric physico-gel
Masato Ishida1, Hideki Sakai, Shinji Sugihara
1Faculty of Science and Technology, Tokyo Universtiy of Science, Yamazaki, Noda, Chiba, Japan.
Chemical & Pharmaceutical Bulletin
|November 6, 2003
Summary
A novel thermo-sensitive copolymer, EOVE200-HOVE400, was synthesized for drug delivery. This copolymer showed controlled release of Vitamin E (VE) in response to temperature changes, indicating its potential for targeted drug delivery systems.
Area of Science:
- Polymer Chemistry
- Materials Science
- Biomedical Engineering
Background:
- Thermo-sensitive polymers offer potential for controlled drug release.
- Developing smart materials for targeted delivery is a key area in pharmaceutical research.
- Copolymers combining different vinyl ether monomers can exhibit tunable properties.
Purpose of the Study:
- To synthesize a thermo-sensitive copolymer (EOVE200-HOVE400) for drug delivery applications.
- To investigate the temperature-dependent release of Vitamin E (VE) from the synthesized copolymer.
- To evaluate the potential of EOVE200-HOVE400 as a drug delivery vehicle.
Main Methods:
- Synthesis of a thermo-sensitive copolymer composed of poly(2-ethoxyethyl vinyl ether) and poly(hydroxyethyl vinyl ether).
- Encapsulation of Vitamin E (VE) within the EOVE200-HOVE400 copolymer matrix.
- Measurement of VE release profiles at varying temperatures (10°C and 30°C).
Main Results:
- The synthesized copolymer EOVE200-HOVE400 exhibited a sol-gel transition temperature of 20.5°C.
- No significant release of VE was observed from the copolymer at 30°C.
- Upon reduction of temperature to 10°C, VE was released from the EOVE200-HOVE400 matrix.
Conclusions:
- The thermo-sensitive copolymer EOVE200-HOVE400 demonstrates controllable drug release properties.
- The material's ability to retain and release VE based on temperature shifts highlights its promise for smart drug delivery systems.
- EOVE200-HOVE400 is a viable candidate for developing temperature-responsive drug delivery platforms.